Catalyst Wire Dossier Catalyst Wire Dossier

Deupirfenidone (LYT-100)

deupirfenidone
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Deupirfenidone (LYT-100), covering 2026-01-09 to 2026-08-13. Get the full timeline:

Most recent: Clinical Trial Results: Study to Determine Potential for Drug-drug Interactions When Co-administering Deupirfenidone (LYT-100) and Nintedanib [Phase 1]

See pricing